Novel Approaches to Cancer Immuno-Therapeutics
A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Medical Biology".
Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 517
Special Issue Editors
Interests: immunology; autoimmunity; cancer immunology; interdisciplinary sciences; protein biochemistry/biophysics; protein complexes
Interests: orthopedics and trauma surgery; musculoskeletal immunology; peri-implant infections; aseptic loosening; osteolysis; bone homeostasis; regeneration
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer immunotherapy uses a person’s immune system to invokes its in-built potential to kill cancer cells. Over the years, checkpoint blockade immunotherapy has revolutionized the field of cancer. Several checkpoint blockade inhibitors to molecules such as PD-1 (programmed cell death 1) and CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) have been approved by the FDA for the treatment of various cancer types. However, many of these treatments have still not reached to the majority of patients, and not all types of cancers respond to them. Additionally, some patients develop immunotherapy-associated adverse events. All of this means that there is still a lot of room for improvement when it comes to these therapies, but also huge potential.
This Special Issue is focused on recent novel developments in cancer immunotherapeutics, development of new approaches to identify novel targets of immunotherapy, and recent developments in combinatorial approaches.
Dr. Youg Raj Thaker
Dr. Frank Alexander Schildberg
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
